Men’s Health Week Arrives Every June

The pattern is well documented. Men are more likely to skip routine screenings, delay care, and stay silent about symptoms until they become serious…

Investing in Our Team: 1nHealth

Last week, the 1nHealth business development team spent two days at an industry summit, focused on the practices that make sponsor relationships stronger. We sent the people who build those relationships into a room full of people who do the same. They felt right at home.

The gap between Alzheimer’s research and the people who need it most

For Dan, CEO and founder of 1nHealth, Alzheimer’s disease is not a therapeutic area on a strategy deck. He lost his grandmother to it. That loss is part of why he built this company, and part of why closing the distance between Alzheimer’s research and the communities it was designed to serve sits at the center of what 1nHealth does.

The dropout problem in antidepressant research is a recruitment problem.

When a psychiatric drug trial struggles to keep participants enrolled, the conversation usually turns to the sites. Site staff get asked to follow up more often, schedule more carefully, and chase harder.
But the data points somewhere else. The pattern that drives dropout in antidepressant research begins well before a patient ever walks into a site. It begins at recruitment.